American Heart Journal
Volume 147, Issue 6 , Pages 953-955 , June 2004

Atrial fibrillation and atrial cardiomyopathy—two sides of the same coin?

  • Ole Dyg Pedersen, MD

      Affiliations

    • Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark
    • Corresponding Author InformationReprint requests: Ole Dyg Pedersen, MD, Specialist in Cardiology, Department of Cardiology, Bispebjerg University Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark.
    • ,
  • Lars Køber, MD, DSMC

      Affiliations

    • Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Christian Torp-Pedersen, DSMC, FESC

      Affiliations

    • Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark

References 

  1. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J. 1959;58:59–70
  2. Allessie MA, Boyden PA, Camm AJ, et al.  Pathophysiology and prevention of atrial fibrillation. Circulation. 2001;103:769–777
  3. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415:219–226
  4. Wijffels MC, Kirchhof CJ, Dorland R, et al.  Atrial fibrillation begets atrial fibrillation (a study in awake chronically instrumented goats). Circulation. 1995;92:1954–1968
  5. Li D, Shinagawa K, Pang L, et al.  Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation. 2001;104:2608–2614
  6. Fuster V, Ryden LE, Asinger RW, et al.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation (executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in Collaboration with the North American Society of Pacing and Electrophysiology). Circulation. 2001;104:2118–2150
  7. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators . A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833
  8. Van Gelder IC, Hagens VE, Bosker HA, et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834–1840
  9. Pedersen OD, Bagger H, Kober L, et al.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 1999;100:376–380
  10. Wachtell K, Letho M, Hornestam B, et al.  Losartan reduces the risk of new-onset atrial fibrillation in hypertensive patients with electrocardiogram left ventricular hypertrofy (the LIFE Study). Eur Heart J. 2003;24(Suppl):504
  11. Ueng KC, Tsai TP, Yu WC, et al.  Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation (results of a prospective and controlled study). Eur Heart J. 2003;24:2090–2098
  12. Madrid AH, Bueno MG, Rebollo JM, et al.  Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation (a prospective and randomized study). Circulation. 2002;106:331–336
  13. Goette A, Arndt M, Rocken C, et al.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 2000;101:2678–2681
  14. Nakashima H, Kumagai K, Urata H, et al.  Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000;101:2612–2617

PII: S0002-8703(04)00054-7

doi: 10.1016/j.ahj.2004.01.015

American Heart Journal
Volume 147, Issue 6 , Pages 953-955 , June 2004

Article Tools